{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}], "original": "By ROBERT CYRAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/08/26/business/26EPIPEN/26EPIPEN-thumbWide.jpg", "legacy": {"wide": "images/2016/08/26/business/26EPIPEN/26EPIPEN-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/08/26/business/26EPIPEN/26EPIPEN-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/26/business/26EPIPEN/26EPIPEN-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "445"}, "width": 600, "subtype": "xlarge", "height": 445}, {"type": "image", "url": "images/2016/08/26/business/26EPIPEN/26EPIPEN-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/26/business/26EPIPEN/26EPIPEN-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"kicker": "Breakingviews", "content_kicker": "Breakingviews", "main": "Debate Over Mylan\u2019s EpiPen Exposes Health Care Flaws"}, "print_page": null, "keywords": [{"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Mylan Inc", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Epinephrine (Drug)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Bresch, Heather", "is_major": "N", "rank": "6", "name": "persons"}], "snippet": "Middlemen make the system incredibly messy, and assistance programs keep things murky; simply reducing the list price of the drug would be better....", "source": "The New York Times", "lead_paragraph": "Middlemen make the system incredibly messy, and assistance programs keep things murky; simply reducing the list price of the drug would be better.", "word_count": "384", "pub_date": "2016-08-26T04:00:00+0000", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/08/26/business/dealbook/debate-over-mylans-epipen-exposes-health-care-flaws.html", "_id": "57bf3a2895d0e021d7982a1c"}